64 related articles for article (PubMed ID: 16537014)
1. Blockage of PI3K/PKB/P27kip1 signaling pathway can antagonize 17 beta-estradiol-induced Ishikawa proliferation and cell cycle progression.
Guo RX; Wei LH; Qiao YH; Wang JL; Tang JM
Chin Med J (Engl); 2006 Feb; 119(3):242-5. PubMed ID: 16537014
[No Abstract] [Full Text] [Related]
2. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
Gu C; Zhang Z; Yu Y; Liu Y; Zhao F; Yin L; Feng Y; Chen X
Cancer Sci; 2011 Mar; 102(3):557-64. PubMed ID: 21205080
[TBL] [Abstract][Full Text] [Related]
3. [Activation of phosphatidylinositol 3-kinase-protein kinase B (PI3K-PKB) induced by 17beta-estradiol in endometrial carcinoma cell (Ishikawa)].
Guo RX; Wei LH; Wang JL; Sun PM; Sun XL
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):469-73. PubMed ID: 15347471
[TBL] [Abstract][Full Text] [Related]
4. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
5. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
6. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract][Full Text] [Related]
7. 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells.
Guo RX; Wei LH; Tu Z; Sun PM; Wang JL; Zhao D; Li XP; Tang JM
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):9-18. PubMed ID: 16567092
[TBL] [Abstract][Full Text] [Related]
8. [Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line].
Yu XX; Shi YA; Zhang LH; Wang YS; Wu S
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):323-7. PubMed ID: 18956651
[TBL] [Abstract][Full Text] [Related]
9. Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro.
Shi M; Zhang H; Li M; Xue J; Fu Y; Yan L; Zhao X
Gynecol Oncol; 2011 Nov; 123(2):387-92. PubMed ID: 21794903
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
Mikami I; Zhang F; Hirata T; Okamoto J; Koizumi K; Shimizu K; Jablons D; He B
Oncol Rep; 2010 Dec; 24(6):1677-81. PubMed ID: 21042767
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphatidylinositol-3-kinase causes cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism.
Gottschalk AR; Doan A; Nakamura JL; Haas-Kogan DA; Stokoe D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1183-8. PubMed ID: 15752900
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
[TBL] [Abstract][Full Text] [Related]
13. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
Moon DO; Lee KJ; Choi YH; Kim GY
Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
[TBL] [Abstract][Full Text] [Related]
14. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
Murillo H; Huang H; Schmidt LJ; Smith DI; Tindall DJ
Endocrinology; 2001 Nov; 142(11):4795-805. PubMed ID: 11606446
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner.
Fujiwara Y; Kawada K; Takano D; Tanimura S; Ozaki K; Kohno M
Biochem Biophys Res Commun; 2006 Feb; 340(2):560-6. PubMed ID: 16378598
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
17. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
[TBL] [Abstract][Full Text] [Related]
18. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway.
Lee SH; Pyo CW; Hahm DH; Kim J; Choi SY
Mol Cells; 2009 Jul; 28(1):37-42. PubMed ID: 19533041
[TBL] [Abstract][Full Text] [Related]
19. Src regulates cell cycle protein expression and renal epithelial cell proliferation via PI3K/Akt signaling-dependent and -independent mechanisms.
Xing J; Zhang Z; Mao H; Schnellmann RG; Zhuang S
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F145-52. PubMed ID: 18434386
[TBL] [Abstract][Full Text] [Related]
20. Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.
Izutani Y; Yogosawa S; Sowa Y; Sakai T
Int J Oncol; 2012 Mar; 40(3):816-24. PubMed ID: 22307336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]